Hypertension in children with chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 12, Issue 4, 2005, Pages 378-384

  Shatat, Ibrahim F ^b   Flynn, Joseph T ^a,c  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Adolescents; Children; Chronic kidney disease; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOSARTAN; RAMIPRIL; TRANDOLAPRIL;

CHILD; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY INFARCTION; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEINURIA; PYELONEPHRITIS; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT;

EID: 25444495873     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.07.002     Document Type: Article

References (34)

1. Kidney Disease Outcomes Quality Initiative (K/DOQI) K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 suppl 1 2004 S1 S290
2. G.L. Bakris, M. Williams, L. Dworkin Preserving renal function in adults with hypertension and diabetes A consensus approach Am J Kidney Dis 36 2000 646 661
3. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents Pediatrics 114 2004 555 576
4. A.V. Chobanian, G.L. Bakris, H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 report JAMA 289 2003 2560 2572
5. North American Pediatric Renal Transplant Cooperative Study 2004 Annual Report 2005 Emmes Corporation Potomac, MD
6. B.A. Fivush, K. Jabs, A.M. Neu Chronic renal insufficiency in children and adolescents The 1996 annual report of NAPRTCS Pediatr Nephrol 12 1998 328 337
7. J.T. Flynn, W.E. Smoyer, T.E. Bunchman Treatment of hypertensive children with amlodipine Am J Hypertens 13 2000 1061 1066
8. T. Wells, V. Frame, B. Soffer A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension J Clin Pharmacol 42 2002 870 880
9. J.M. Sorof, T. Poffenbarger, R. Portman Abnormal 24-hour blood pressure patterns in children after renal transplantation Am J Kidney Dis 35 2000 681 686
10. S.S. Nagasako, P.C. Koch Nogueira Arterial hypertension following renal transplantation in children - a short-term study Pediatr Nephrol 18 2003 1270 1274
11. US Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2002 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
12. M.J. Klag, P.K. Whelton, B.L. Randall Blood pressure and end-stage renal disease in men N Engl J Med 334 1996 13 18
13. J.C. Peterson, S. Adler, J.M. Burkart Blood pressure control, proteinuria, and the progression of renal disease The Modification of Diet in Renal Disease Study Ann Intern Med 123 1995 754 762
14. M. Mitsnefes, P.-L. Ho, P.T. McEnery Hypertension and progression of chronic renal insufficiency in children A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTICS) J Am Soc Nephrol 14 2003 2618 2622
15. A.-M. Wingen, C. Fabian-Bach, F. Schaefer Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children Lancet 349 1997 1117 1123
16. M. Soergel, F. Schaefer Effect of hypertension on the progression of chronic renal failure in children Am J Hypertens 15 suppl 2002 53S 56S
17. B.L. Riser, P. Cortes, X. Zhao Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formationin the rat J Clin Invest 90 1992 1932 1943
18. E. Johnsson, B. Rippe, B. Haraldsson Reduced permselectivity in isolated perfused rat kidneys following small elevations of glomerular capillary pressure Acta Physiol Scand 150 1994 201 209
19. A.J. Lewington, M. Arici, K.P. Harris Modulation of the rennin-angiotensin system in proteinuric renal disease Are these added benefits? Nephrol Dial Transplant 16 2001 885 888
20. P. Zucchelli, A. Zuccala Progression of renal failure and hypertensive nephrosclerosis Kidney Int 68 suppl 1998 S55 S59
21. C. Weigert, K. Brodbeck, F.C. Brosius 3rd Evidence for a novel TGF-β1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters Diabetes 52 2003 527 535
22. K.J. McLaughlin, P.N. Harden, S. Ueda The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases Hypertension 28 1996 912 915
23. P. Ruggenenti, A. Perna, G. Gherardi Randomized placebo-controlled trial of effect of remipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Lancet 352 1998 1252 1256
24. G. Maschio, D. Alberti, G. Janin Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
25. T.H. Jafar, C.H. Schmid, M. Landa Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease A meta-analysis of patient-level data Ann Intern Med 135 2001 73 87
26. I. Giatras, J. Lau, A.S. Levey Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease A meta-analysis of randomized trials Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 127 1997 337 345
27. A.V. Kshirsagar, M.S. Joy, S.L. Hogan, R.J. Falk, R.E. Colindres Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease A systematic overview of randomized placebo-controlled trials Am J Kidney Dis 35 2000 695 707
28. R.T. Gansevoort, D. de Zeeuw, S. Shahinfar Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease J Hypertens 12 suppl 1994 S37 S42
29. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
30. N. Nakao, A. Yoshimura, H. Morita Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) A randomized controlled trial Lancet 361 2003 117 124
31. T. Seeman, J. Dusek, K. Vondrak Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases Am J Hypertens 17 2004 415 420
32. E. Wühl, O. Mehls, F. Schaefer ESCAPE Trial Group Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure Kidney Int 66 2004 768 776
33. D. Ellis, A. Vats, M.L. Moritz Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria J Pediatr 143 2003 89 97
34. R.P. Woroniecki, J.T. Flynn How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol 20 2005 791 797